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Abstract
Background: Anxiety and depression are frequently and highly occurring mental disorders in patients with
tuberculosis. When depression and anxiety co-morbid with tuberculosis, it leads to poor adherence to anti TB
medication, which is important barrier to global control of tuberculosis & increases the risk of morbidity and
mortality due to TB. Cross sectional study was conducted to assess prevalence and correlates of depression and anxiety
among patients with TB at WolaitaSodo University Hospital and Sodo Health Center, WolaitaSodo, Ethiopia.
Methods: Institution based cross-sectional study was conducted in 2014.A total of 417 TB patients, who had regular
follow up at WolaitaSodo University Hospital and Sodo Health Center, WolaitaSodo, South Ethiopia, were
recruited to assess depression and anxiety and its associated correlates. Depression and anxiety were assessed
through face to face interviews by trained psychiatry nurses using the hospital anxiety and depression scale
(HADS). Correlates for depression and anxiety were assessed using a structured questionnaire, Oslo social
support scale and TB stigma Scale.
Results: The prevalence of depression and anxiety among patients with TB were 43.4 % (181) and 41.5 %
(173) respectively. When we adjusted for the effect of potential confounding variables, patients who had
co-morbid HIV infection [AOR = 5.90,(95 % CI: 2.34,15.93)], poor social support [AOR = 18.06, (95 % CI:11.21,25.45)] &
perceived TB stigma [AOR = 10.86, (95 % CI:10.26,23.47)] were more likely to have depression as compared to individuals
who had no co-morbid HIV infection, good social support and no perceived TB stigma respectively. Patients who had
co-morbid HIV infection [AOR = 9.61,(95 % CI:3.56,25.96)], poor social support [AOR = 8.93,(95 % CI: 5.01,15.94)], perceived
TB stigma [AOR = 3.11,(95 % CI:1.78,5.42)], being female [AOR = 1.72 (95 % CI: 1.06, 2.95)], current substance
use[AOR = 4.88, (95 % CI: 1.79, 13.28)] and being on intensive phase of TB treatment [AOR = 1.91, (95 % CI:
1.08, 3.39)] were more likely to have anxiety as compared to individuals who had no co-morbid HIV infection, good
social support, no perceived TB stigma, being male and being on continuous phase of TB treatment respectively.
Conclusion: Developing guidelines and training of health workers in TB clinics is useful to screen and treat depression
and anxiety among TB patients.
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Background
Tuberculosis is a chronic infectious disease caused by
Mycobacterium tuberculosis. It is one of the leading
causes of morbidity and mortality worldwide [1, 2].
According to WHO 2012 estimate, 2 billion people have
latent TB, while another 3 million people worldwide die
each year due to TB [3]. It remains a major global health
problem & causes ill-health among millions of people
each year and ranks as the second leading cause of death
from an infectious disease worldwide, after HIV/AIDS
[4]. According to WHO 2013 global TB control report,
Ethiopia ranks 7th among the 22 high burden countries
in the world and 2nd in Africa [5].
Depression is a common mental disorder that presents
with depressed mood, loss of interest or pleasure,
decreased energy, feelings of guilt or low self-worth,
disturbed sleep or appetite, and poor concentration [6].
It is one of the leading causes of disease burden affecting
121 million people worldwide. Depression can lead to
suicide. Suicide contributes for the loss of about 850,000
lives every year [7]. In general population, the life
time risk of depression is 10 % to 25 % for women
and 5 % to 12 % for men [8]. In Ethiopia, a study
done in Addis Ababa showed that the life time preva-
lence is 2.7 % for depressive episodes, 0.2 % for
recurrent episodes, 0.3 % for bipolar and 1.6 % for
persistent mood disorder [9]. However, the prevalence
of depression in those with chronic illness in the
world is much higher, i.e. 25 % to 33 % [8].
Anxiety is a vague, subjective, non-specific feeling of un-
easiness, apprehension, tension, (excessive nervousness)
fears, and a sense of impending doom, irrational avoidance
of objects or situation and anxiety attack [6]. The anxiety
disorders make up one of the most common groups of
psychiatric disorders and the National co-morbidity study
reported that one of four persons met the diagnostic
criteria for at least one anxiety disorder and that there is a
12-month prevalence rate of 17.7 percent [10].
Anxiety and depression are the most frequently occur-
ring mental disorders in the general population [11].
Studies conducted in different countries on prevalence
of depression and anxiety among TB patients shows that
46.3 % (anxiety), 47.2 % (depression) in Pakistan [11],
72.88 % (anxiety), 38.98 % (depression) in Romania [12],
40.67 % (anxiety), 9.93 % (depression) in Greece [13],
45 % (depression) in Nigeria [14], 61 % (depression in
Kenya [15]. The studies indicate that there is high preva-
lence of depression and anxiety among TB patients com-
pared to general population which is about 3–17 % [16],
and 7 % to 82.3 % [17], respectively.
Moreover, depression often comes with symptoms of
anxiety. These problems can become chronic or recur-
rent and lead to substantial impairments in an individ-
ual’s ability to take care of his or her everyday
responsibilities [5]. The presence of depression and anx-
iety has a negative influence on quality of life, health
care cost and self-care. This leads to decreased resist-
ance to infections, so it adversely affects the patient’s
compliance to TB treatment that can increase mortality
from the disease [18]. Despite their known effect on the
population, there is very little data available in the study
area. Therefore, this study was planned to determine the
prevalence and correlates of depression and anxiety
among patients with TB at Wolaita Sodo University
Hospital and Sodo health center, Wolaita Sodo, Ethiopia.
Methods
Study Setting and population
The study was a cross sectional design, conducted from
April to May, 2014 in Wolaita Sodo University Hospital
and Sodo Health Center, South Nation Nationalities re-
gional state of Ethiopia. All adult patients (age ≥ 18) with
tuberculosis who had regular follow were included in the
sample. Critically ill patients were excluded from the study.
Among 948 TB patients who had regular follow up at
TB clinics, 424 TB patients were recruited for the study.
Study participants were included using systematic
random sampling technique. Seven patients refused to
participate in the study.
Data collection
Data were collected by trained psychiatry nurses using
pretested interviewer administered questionnaire. The
data collection instrument had different components.
The first part includes socio-demographic characteristics
(age, education, occupation, marital status and others).
Social support characteristics were collected by Oslo 3-
item social support scale. Oslo 3-item social support
scale is 3-item questionnaire commonly used to assess
social support. It has the sum score scale ranging from 3
to 14 with three broad categories: “poor support” 3–8,
“moderate support” 9–11 and “strong support” 12–14
[19]. It was reliable in the study (Cronbach's α = 0.91).
Stigma felt by TB patients was collected by 12-item per-
ceived TB stigma scale. It consisted of four-point Likert
scale (strongly disagree, disagree, agree, strongly agree)
questions concerning perceived isolation, shame, guilt
and disclosure of the TB status. Item scores of the
stigma questions were summed to construct a single
stigma variable. Participants were classified as having
or not having perceived stigma using the mean of the
stigma variable as cut-off point [20]. The instrument
was adopted and translated to Amharic language and
back to English and highly reliable in the study
(Cronbach's α = 0.89). An outcome variable (presence
of anxiety and depression) was collected by Hospital
Anxiety & Depression scale (HADS). HADS is a 14-
item questionnaire, commonly used to screen for
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symptoms of anxiety and depression. The 14-item can
be separated into two 7-item sub-scales for anxiety
and depression. It was validated in Ethiopia and its
internal consistency was 0.78 for anxiety, 0.76 for de-
pression subscales and 0.87 for full scale. The scales
use a cut off score for anxiety and depression of
greater than or equal to 8 [21].
Data Processing and Analyses
Data were analyzed using SPSS version 20. Bivariate ana-
lysis was done to see the association of each independent
variable with the outcome variable. Potential confounders
(important) variables were entered into binary logistic re-
gression model to identify the effect of each independent
variable with the outcome variables. A p-value of less
than 0.05 was considered statistically significant, and
adjusted odds ratio with 95 % CI was calculated to
determine association.
Ethical Consideration
Ethical clearance was obtained from the Research and
Ethics Review Committee of the Institute of Public
Health (University of Gondar) and Amanuel Mental
Specialized Hospital. Permission letter was obtained
from Wolaita zone Health Department and submitted to
Sodo Health Center. Written informed consent was
obtained from each study participant and they were
informed about their rights to interrupt the interview at
any time. Confidentiality was maintained at all levels of
the study. Tuberculosis patients who were found to have
moderate to severe depression and anxiety were referred
to psychiatry clinics for further investigations.
Results
Socio-economic and demographic characteristics
A total of 417 participants were recruited for the study
which makes the response rate 98.6 %. The mean ((± SD)
age of the respondents was 34.52 (±11.01) years. Among
the respondents, 291(69.8 %) were in age range of 25 –
49 years, 241(57.8 %) were male, 266 (63.8 %) were
Wolaita ethnic background, 199 (47.7 %) were never
married (single), 129 (30.9 %) were attended primary
education, and 189 (45.3 %) were protestant religion
followers. The median monthly income of the participants
was 700 (Table 1).
Clinical and psychosocial characteristics of the
respondents
Two hundred eighty seven (68.8 %) patients were with
diagnosis of pulmonary TB, 341 (81.8 %) were in new
TB treatment category, 245 (59.2 %) had 6–12 months
duration of illness, 270 (64.9 %) were in intensive phase
of TB treatment, 229 (54.9 %) had good social support,
177 (42.4 %) had perceived TB stigma. From all study
participants 49 (11.8 %) had co-morbid HIV illness, 30
(7.2 %) were currently substance (khat, cigarette and
alcohol) users (Table 2).
Prevalence of depression and anxiety among TB patients
The prevalence of depression, anxiety and co-morbid
depression and anxiety among TB patients were 43.4 %,
41.5 %, and 40.6 % respectively.
Factors associated with depression & anxiety among
patients with TB
Binary logistic regression analysis revealed that co-morbid
chronic illness, good social support and perceived TB
Table 1 Distribution of TB patients at Wolaita Sodo University
Hospital & Sodo Health Center, SNNPRS, Ethiopia, 2014
Variables Frequency Percent (%)
Age 18–24 years 88 21.1
25–49 years 291 69.8
> = 50 years 38 9.1
Sex Male 241 57.8
Female 176 42.2




Education status No formal education 78 18.7
Primary education 129 30.9
Secondary education 117 28.1
Higher education 93 22.3








Occupation status Government employee 76 18.2
Private employee 85 20.4
Merchant 51 12.2
Farmer 15 3.6
House wives 52 12.5
Jobless 49 11.8
Students 89 21.3
Monthly income <735 ETB 212 50.8
735–1176 ETB 86 20.6
> = 1176 ETB 119 28.6
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stigma were statistically significant with depression. Being
female, phase of treatment, co-morbid chronic illness,
good social support, perceived TB stigma, current sub-
stance (khat, cigarette & alcohol) use were statistically
significant with anxiety (Table 3 & 4).
Discussion
Prevalence and factors associated with depression among
patients with Tuberculosis
This study revealed that the prevalence of depression
was 43.4 %. The finding was similar with other studies
carried out in Nigeria 41.9 % [22], in Ibadan Nigeria
45.5 % [14] and in Pakistan 46.3 % [11]. On the other
hand, the current study finding was higher than the
study done in Nigeria 27 % [23] and Greece 9.93 % [13]
and lower than the study was done in Kenya 61 % [15],
in India 62 % [24] and 82 % [25]. The variation might be
due to the difference in study design, data collection
tool, sample size and difference in study participants.
One of the factors significantly associated with depres-
sion was HIV and TB co-infection. The finding is similar
with the study conducted in Jimma, Ethiopia [26] and
South Africa [27]. Being diagnosed with HIV, which is a
terminal life-long disease associated with high levels of
stigma may also lead to high rates of mental disorders
[27]. Hence, TB/HIV co-infected patients can be at
higher risk of common mental disorders as a result of
stigma and discrimination by the society [28].
Patients who had perceived TB stigma were about 11
times more likely to have depression than their counter-
parts. This is similar with a study conducted in Pakistan
[29]. Previous study has proven that presence of per-
ceived stigma is highly associated with depression.
People with perceived stigma may have a low self image
and be socially isolated which may predispose them
depression [30].
Furthermore, the study indicated that poor social sup-
port was significantly associated with depression. The
finding is similar with other studies in Nigeria [23]. Lack
of (poor) social support and somatic illness may lead to
increased psychological distress. On the other hand,
good social support is vital for those with good health in
prevention of depression [31].
Prevalence and factors associated with anxiety among
patients with Tuberculosis
The study showed that the prevalence of anxiety among
TB patients was 41.5 %. The finding is similar with the
study conducted in Pakistan 46.2 % [11] and in Greece
40.67 % [13] but lower than the study conducted in
Romania 72.88 % [12]. The variation might be due to
the difference in data collection tool which was STAI
scale, might over estimate anxiety symptoms among TB
patients in Romania.
With respect to gender, being female was significantly
associated with anxiety. Different studies showed that anx-
iety disorders are more common in females than males.
Biological factors might contribute for the differences.
Similar to depression, HIV and TB co-infection was
significantly associated with anxiety. A similar finding
was observed in a study conducted in Jimma, Ethiopia
[26]. TB/HIV co-infected patients can be at higher risk
of common mental disorders because of stigma and
discrimination by the society [28].
Anxiety was also significantly higher among patients
who had perceived TB stigma. A similar finding was
seen in a study conducted in Pakistan [29]. Previous
study has proven that presence of perceived stigma is
highly associated with anxiety. People with perceived
stigma may have a low self image and be socially isolated
which may predispose them anxiety [30].
Anxiety was significantly higher among patients who
were in intensive phase of TB treatment than those of
patients in continuation phase of treatment. This is due
to the fact that the symptoms of tuberculosis tend to be
prominent in the intensive phase where patients get re-
lieved as they progress to the continuation phase of TB
treatment This may indicate Patients in the continuation
Table 2 Description of clinical, psychosocial & substance use
factors among patients with TB at Wolaita Sodo University
Hospital and Sodo Health Center, SNNPRS, 2014.
Variables Frequency Percent (%)
Classification Pulmonary TB 287 68.8
Extra-pulmonary TB 130 31.2
Category of treatment New 341 81.8




Duration of illness <6 months 25 6
6–12 months 247 59.2
> = 12 months 145 34.8
Phase of treatment Intensive phase 270 64.7
Continuation phase 147 35.3







Good social support Yes 229 54.9
No 188 45.1
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phase of anti-TB treatment, the physical and functional
status of the patients could improve significantly which in
turn brings improved mental health status of individuals.
Regarding to social support, anxiety was significantly
higher among patients who had poor social support than
patients who had good social support. Lack of (poor)
social support and somatic illness (TB) may lead to
increased psychological distress (mental disorders); on
the other hand, good social support is vital for those
with good health in prevention of anxiety [31].
The study also revealed that use of substance (khat,
cigarette & alcohol) was significantly associated with
anxiety. This could be due to the fact that anxious
patients are more prone to use substances to relief
themselves from the stress or anxiety symptoms.
Many studies established that 25-50 % of people with
substance (khat, cigarette & alcohol) use related prob-
lem meet diagnostic criteria of anxiety disorder some
time in their life time [32]. For instance, one study
conducted on smoking in relation to anxiety and de-
pression showed, anxiety had strong association with
cigarette smoking [33, 34].
Conclusion
The prevalence of depression, anxiety and co-morbid
depression and anxiety (40.6 %) among TB patients were
high. Both depression and anxiety had statistically signifi-
cant association with co-morbid HIV infection, perceived
TB stigma and poor social support. Being female sex,
current substance (khat, alcohol and cigarette) use and
being on intensive phase of TB treatment had statistically
significant association with anxiety only. TB clinics should
develop guidelines to screen and treat depression and anx-
iety among TB patients. Further research on risk factors
of depression and anxiety should be conducted to
strengthen and broaden the current findings.
Table 3 Factors associated with depression among patients with TB at Wolaita Sodo University Hospital and Sodo Health Center,
SNNPRS, Ethiopia, 2014
Explanatory Variables Depression COR,95 % (CI) AOR,95 % (CI)
Yes No
Age n = 417
18–24 years 27 61 1 1
25–49 years 129 162 1.79, (1.08, 2.99) 0.78(0.30, 2.03)
> = 50 years 25 13 4.34, (1.94, 9.76) 1.09 (0.20, 5.92)
Educational status n = 417
No formal education 48 30 3.20, (1.71, 5.99) 2.92 (0.91, 9.35)
Primary education 59 70 1.68, (0.97, 2.93) 2.58 ( 0.95 ,6.96)
Secondary education 43 74 1.16, (0.66, 2.06) 1.50 (0.57, 3.94)
Higher education 31 62 1 1
Classification n = 417
Pulmonary TB 150 137 3.49, (2.19, 5.57) 1.68(0.97, 4.17)
Extra-pulmonary TB 31 99 1 1
Phase of treatment
Intensive phase 127 143 1.53, (1.01, 2.31) 0.59 (0.29,1.23)
Continuous phase 54 93 1 1
Co-morbid chronic illness
HIV/AIDS 34 15 3.83, (2.01, 7.29) 5.90(2.34, 15.93)**
Other chronic illness 19 5 6.41, (2.34, 17.59) 1.07 (0.37, 3.07)
No chronic illness 128 216 1 1
Good social support
Yes 29 200 1 1
No 152 36 29.12, (17.10, 49.59) 18.06(11.21, 25.45)*
Perceived TB Stigma
Yes 148 29 32.01, (18.62, 55.02) 10.86(10.26, 23.47)*
No 33 207 1 1
*significant association (p-value < 0.05) ** significant association (p-value < 0.01) Substance use = khat, cigarette and/or alcohol use .Other chronic illness = hypertension,
renal diseases, cardiovascular diseases and diabetes
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Limitation of the study
This study was cross-sectional study design, it did not
allow establishing a temporal relationship between
depression and anxiety and significant associated factors
like substance (khat, cigarette and alcohol) use. Add-
itionally, no detailed validation study was done for the
Table 4 Factors associated with anxiety among patients with TB at Wolaita Sodo University Hospital and Sodo Health Center,
SNNPRS, Ethiopia, 2014
Explanatory Variables Anxiety COR,95 % (CI) AOR,95 % (CI)
Yes No
Sex n = 417
Male 89 152 1 1
Female 84 92 1.56, (1.05, 2.31) 1.72, (1.06, 2.95)**
Educational status n = 417
No formal education 45 33 3.01, (1.61, 5.64) 0.70,(0.23,2.11)
Primary education 54 75 1.59, (0.91, 2.79) 0.80,(0.32,1.99)
Secondary education 45 72 1.38, (0.78, 2.45) 1.31,(0.54,3.20)
Higher education 29 64 1 1
Job n = 417
Government employed 28 48 1 1
Private employed 29 56 0.89, (0.47, 1.69) 0.79, (0.33, 1.93)
Merchant 20 31 1.11, (0.53, 2.29) 0.65, (0.23, 1.88)
Farmer 6 9 1.14, (0.37, 3.55) 0.70, (0.14, 3.56)
House wives 29 23 2.16, (1.05, 4.44) 1.24, (0.88, 6.23)
Jobless 26 23 1.94, (1.03, 4.02) 2.40, (0.62, 5.12)
Students 35 54 1.11, (0.59, 2.09) 2.34, (0.43, 3.32)
Category of treatment
New 134 207 1 1
Return after default 16 21 1.18, (0.59, 2.34) 1.86,(0.71,4.87)
Relapse 23 16 2.22, (1.13, 4.36) 1.01,(0.39, 2.65)
Phase of treatment
Intensive phase 130 140 2.25,(1.46, 3.45) 1.91,(1.081, 3.39)**
Continuous phase 43 104 1 1
Co-morbid chronic illness
HIV/AIDS 42 7 11.95, (5.21, 27.43) 9.61, (3.56, 25.96)*
Other chronic illness 16 8 3.98, (1.66, 9.58) 2.62, (0.91, 7.58)
No chronic illness 115 229 1 1
Good social support
Yes 36 193 1 1
No 137 51 14.40, (8.92, 23.26) 8.93, (5.01, 15.94)*
TB Stigma
Yes 123 54 8.66, (5.54, 13.53) 3.12, (1.78, 5.42)**
No 50 190 1 1
Substance use
Yes 21 9 3.607, (1.61, 8.09) 4.88, (1.79,13.28)*
No 152 235 1 1
* Significant association (I-value < 0.05) **- significant association (p-value < 0.01)
Substance use = khat, cigarette and/or alcohol use other chronic illness = hypertension, renal diseases, cardiovascular diseases and diabetes
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perceived TB-stigma scale and Oslo 3-item social sup-
port scale. Also, substance use related factor was not
assessed by standard tool.
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